Stock TRAW TRAWS PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Traws Pharma, Inc.

Equities

TRAW

US68232V8019

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.574 USD -1.37% Intraday chart for Traws Pharma, Inc. -7.52% -23.02%
May. 15 Traws Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Upgrades Onconova Therapeutics to Buy From Neutral, Price Target is $11
MT
Ladenburg Thalmann Starts Onconova Therapeutics at Buy With $7 Price Target
MT
ONCONOVA THERAPEUTICS : Guggenheim Starts Onconova Therapeutics at Buy With $4 Price Target
MT
ONCONOVA THERAPEUTICS : Noble Capital Upgrades Onconova Therapeutics to Outperform From Market Perform, Adjusts Price Target to $0.46 From $0.30
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRAW Stock
  4. News Traws Pharma, Inc.
  5. Analyst Reco.